CN1127969C - Hyperosteogeny treating medicine - Google Patents
Hyperosteogeny treating medicine Download PDFInfo
- Publication number
- CN1127969C CN1127969C CN01107879A CN01107879A CN1127969C CN 1127969 C CN1127969 C CN 1127969C CN 01107879 A CN01107879 A CN 01107879A CN 01107879 A CN01107879 A CN 01107879A CN 1127969 C CN1127969 C CN 1127969C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- treatment
- hyperosteogeny
- kilograms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses medicine for treating hyperosteogeny, which belongs to one of medicine for treating osteopathy. The present invention is characterized in that the effective components of the medicine mainly comprise safflower or red sage root or 18 to 30% of motherwort, 20 to 30% of angelica, 20 to 30% of eucommia bark, 10 to 20% of achyranthes root and 10 to 18% of scrophularia root. The medicine can effectively treat limb numbness, acid swollen pain, weakness, spasticity, crooked feet, head section pain, dizziness, nausea, vomiting, tinnitus, blurred vision, chest stuffiness, palpitation, etc. because of hyperosteogeny. Besides, diseases have no recurrence after curing. The present invention has no toxic and side effect, and has low cost because the ingredients are normal medicine and few.
Description
The present invention relates to a kind of medicated wine for the treatment of hyperosteogeny, belong to one of medicine of treatment osteopathia.
Hyperosteogeny is the normal disease of suffering from of middle-aged and elderly people, and is main relevant with people's physiological ageing, and also relevant with people institute work taken up, as the driver, the personnel that bend over one's desk working for a long time are engaged in the more single physical labourer of work post for a long time, easily suffer from hyperosteogeny.Mainly occur in people's cervical vertebra, lumbar vertebra, elbow joint, leg joint.Its association symptom is mainly: numb limbs and tense tendons, swelling and pain, unable, spastic unable, lame fall, head pain, dizzy, nauseating, vomiting, tinnitus, blurring of vision, chest are stuffy, nervous etc.The method of treatment hyperosteogeny is mainly by excision, acupuncture, traction, external used medicine, endo-medicine etc. at present.And Drug therapy is divided into external used medicine, innerlich anwenden thing.The problem that operative treatment exists have following some, dangerous high, expense is high, postoperative bony spur can also be regenerated and the post-operative recovery phase long, painful big etc.Though acupuncture and moxibustion therapy also produces effect, control table and do not effect a permanent cure, not only can not cure, and cause cross infection easily.Though traction can temporarily increase the affected part gap, removes several days pain,, also caused the damage of affected part surrounding soft tissue because of use throughout the year.Medicine for external use as " Tai Ji refreshing card " etc., owing to be topical therapeutic, short medical history patient is had certain curative effect, but cure rate is not high, and is lower to long medical history patient cure rate.And bigger to skin irritation, cause allergy easily, fester, multi-section position patient has been increased financial burden.And for example GUZHIZENGSHENG YITIELING mainly play analgesic activity, and the effect of curing the disease is undesirable, and skin is also caused allergy, festers.Oral medicine such as pain-relieving liquid, anti-hypertrophy capsule etc., they contain the analgesic composition, and its curative effect is the short time, in case drug withdrawal does not reach the purpose of curing the disease just repeatedly.And because of the patient takes for a long time, its stomach, intestinal etc. are caused damage, Drug resistance strengthens.
The objective of the invention is, a kind of medicated wine for the treatment of hyperosteogeny is provided, its cure rate height, curative effect is fast, has no side effect, and cost is low, does not recur.
The objective of the invention is to come by the following technical programs.
The medicated wine of this treatment hyperosteogeny, it is to put into Chinese liquor by the raw material of Chinese medicine of following weight percentage ratio to make Flos Carthami or Radix Salviae Miltiorrhizae or Herba Leonuri 18-30%, Radix Angelicae Sinensis 20-30%, Cortex Eucommiae 20-30%, Radix Achyranthis Bidentatae 10-20%, Radix Scrophulariae 10-18% basically.
The percentage by weight of raw material of Chinese medicine is Flos Carthami or Radix Salviae Miltiorrhizae or Herba Leonuri 18-25%, Radix Angelicae Sinensis 22-28%, Cortex Eucommiae 20-28%, Radix Achyranthis Bidentatae 12-18%, Radix Scrophulariae 12-15%.
Also have Moschus in the raw material of Chinese medicine, the percentage by weight of Moschus is 0,5-1,5%.
The helper component of this medicine is a Chinese liquor.Its effect is the effective ingredient in the lixiviate raw material of Chinese medicine, makes the best effect of raw material of Chinese medicine performance.
Technical solution of the present invention has following function, activating blood and removing stasis, and removing pathogenic heat from blood and toxic substance from the body, expectorant powder junction, a surname addiction, dispelling cold by warming the meridian dispel the wind.Its main cause is that the active component of this medicine has adopted Flos Carthami or Radix Salviae Miltiorrhizae or the Herba Leonuri with the effect of invigorating blood circulation, Radix Achyranthis Bidentatae; The strengthening by means of tonics medicine, Radix Angelicae Sinensis, the Cortex Eucommiae; The antiinflammatory antipyretic, Radix Scrophulariae.And prescription rationally.After increasing the awaking drug Moschus, more strengthened the curative effect of medicine.Because Flos Carthami, Radix Salviae Miltiorrhizae, Herba Leonuri can serve the same role after making up with other four kinds of component Radix Angelicae Sinensis, the Cortex Eucommiae, Radix Achyranthis Bidentatae, Radix Scrophulariae, thus among the three, select one of them and other four in combination of components get final product.Because the active component scientific formulation of this medicine, rationally, the function uniqueness, so it can effectively treat because of the numb limbs and tense tendons that hyperosteogeny causes, swelling and pain, unable, spastic unable, lame fall, head pain, dizzy, nauseating, vomiting, tinnitus, blurring of vision, chest stuffy, nervous etc., and do not recur after the treatment, have no side effect.Again because of raw material of Chinese medicine is common Chinese herbal medicine, and amount is few, so cost is low.
Its clinical treatment situation is as follows:
Since 1989 utilize this medicine treatment hyperosteogeny, accepted treatment by 262 patients.Wherein the age accounts in 35-45 year and accounts for 75% more than 25%, 45 years old.Wherein the women accounts for 70%, and the male accounts for 30%.In hyperosteogeny, the cervical spondylosis hypertrophy accounts for 30% greatly, and hyperosteogeny accounts for 2%, and hyperosteogeny accounts for 30%, and the knee hypertrophy accounts for 35%, and the foot hypertrophy accounts for 3%.Effective percentage 100%, cure rate 95%.
1, clinical judgment should the disease standard: primary disease is comprehensively judged through detection meanss such as X sheet, CT sheet, nuclear magnetic resonance, NMR mainly according to the symptom analysis of patient's affected part, is analyzed, makes a definite diagnosis.So that get rid of the symptom that spinal canal stenosis brought that causes because of prolapse of lumbar intervertebral disc, non-hyperosteogeny.Get rid of serious cardiac, hyperpietic simultaneously and to the wine allergy sufferers.
2, treatment standard: (1), effectively, eat this medicine after course of treatment, the sx that causes because of hyperosteogeny, and the mitigation symptoms persistent period be effective greater than 20 days.(2), cure the transference cure that causes because of hyperosteogeny, and not recurring in a year.
3, compound method:,, and be ground into powdery in the ratio preparation of its percentage by weight according to the raw material of Chinese medicine in this medicated wine.The powdery raw material of Chinese medicine is put into the container that fills Chinese liquor to be soaked 5-30 days.The weight ratio of raw material of Chinese medicine and Chinese liquor is raw material of Chinese medicine: Chinese liquor=1: 1,3-2,5.
4, the course of treatment: be 12 days each course of treatment, and the interval is 7 days between the course of treatment and the course of treatment.
5, every day medicining times and dosage: take medicine on an empty stomach, one day twice, obey 30-45 gram medicated wine (comprising medicated powder) at every turn, early service once after ante cibum, the supper.
6, symptom after taking medicine and the treatment recovery time: after obeying this pact, its treatment is divided into three phases: reaction period, transition period, convalescent period.Patient treatment time and cure time, relevant with patient's the state of an illness, general, just horse back therapist of symptom has just been arranged, thoroughly to cure in 25-40 days, the longest cured person of time is drug withdrawal later six months, this patient's medical history 15 years, affected part has caused other pathological changes because of hypertrophy.
(1) reaction period: the reaction period is the sx phase, generally begins in 3-6 days behind this medicine of clothes.The medical history weak point then along with finishing for first course of treatment and finishing; Medical history is long then can extend to second mid-term course of treatment, and this class patient generally obeys again and can finish 0,5 to 1 course of treatment.
(2) transition period: promptly be after the reaction period, return to the symptom phase before taking medicine.Its transition period is also relevant with medical history length, the medical history weak point, several days time, medical history length, reach a course of treatment.
(3) recover recovery period: after being the transition period, from sx to the complete obiteration phase.If the hypertrophy position does not cause other pathological changes (as joint deformity, the sticking connection of soft tissue, spinal canal stenosis etc.).General 25-60 days.If affected part has caused other pathological changes, convalescent period just prolongs so.But just recover half a year normal at most fully.
7, therapeutic effect: according to treatment to 262 patients.Effective percentage 100%, cure rate 95%.
8, model case introduction:
(1) Qu Shuzhi: woman, 32 years old, lumbar vertebra 5-4-3-2 joint has lip sample hypertrophy, and there is pointed hypertrophy at the edge, and the patient is at medication the first two years, affected part begins to have slight property paroxysmal pain, afterwards more and more heavier, reveal any symptoms has: activity can cause waist and lower part of the body pain and numbness behind sitting, the lying on bed for a long time, particularly can not bend over, movable a little back sx also has above symptom after the activity time is long and produces.By affected part the point pain is arranged with hands.Occurred the reaction of pain property in first course of treatment of taking medicine, reconstructed image did not appear adding in second course of treatment, first quarter moon symptom complete obiteration after the drug withdrawal.Treatment time is 29 days, recovery from illness in 45 days, not recurrence in existing 9 years so far.
(2) Qu Cuihua: the woman, 48 years old, cervical vertebra all had hypertrophy in various degree, and the C5 cone is for very, C6,7 narrowings of intervertebral space.Symptom shows as: cervical region rotates uncomfortable, and left side shoulder to right shoulder has fiber crops to expand, ache, and there is mild pain in left half a head portion, and left side shoulder is appeared on the stage or cervical region rotates and all can increase the weight of symptom, and Changes in weather also can increase the weight of.Promptly take this medicine after the diagnosis.Reaction period, transition period are as good as with last example basically, because of this patient's medical history weak point, so symptom is complete obiteration after drug withdrawal.So far two-and-a-half years do not recur.
(3) Wang Cuilian: woman, 69 years old, left knee hyperplasia.Symptom: can not cross one's legs, knee motion is limited, has the point pain as the affected part of walking down behind the sitting lying on bed for a long time, and occur walking lamely.Because period of disease is short, symptom disappears substantially after one and half courses of treatment of taking medicine, and is completely recovered after two courses of treatment, and existing a year and a half does not recur so far.
(4) Lin Huifang: the woman, 69 years old, hyperosteogeny was pointed, the compressing cerebrovascular, the morbidity history is unclear, and the first four years of taking medicine begins to increase the weight of, and dizzy sense is often arranged, and vomiting, migraine, head are seriously limited to the shoulder activity.Taking medicine the phenomenon of falling in a swoon occurred the previous year, and just showed effect once about every 15-30 days, each outbreak, head, shoulder can not have a little and to rotate, otherwise just increase the weight of dizzy, headache, symptom such as feel sick, the patient takes analgesic throughout the year, and just the medicine with blood vessel dilating is treated when outbreak.During first course of treatment, no longer take other medicines and other treatment at this medicine of clothes.Migraine disappears after first course of treatment, and other symptom also obviously alleviates, and after second course of treatment, cervical region rotates substantially freely, and other symptom is eliminated fully.After take a course of treatment again, to consolidate effect, 1 year half so far not the recurrence.Treat and promptly healed in 50 days.
(5) Zhang Pengliang: the man, 55 years old, two knee joint hypertrophy, right knee joint is attached most importance to, and medical history has 15 years.Before taking medicine, the distortion of patient's affected part joint, red and swollen around the affected part.The adhesion of diagnosis affected part soft tissue has hydrops.During bad weather, sx.Before this medicine of clothes, disability is 3 years, by the crutch walking, takes analgesic throughout the year.The patient takes this medicine afterreaction phase and is extended down to second mid-term course of treatment, and the transition period reaches a treatment time.After taking the 3rd course of treatment, this patient can get rid of and turn the battle walking, and the right lower limb of patient is still lame during walking, and the affected part redness obviously goes down.After the drug withdrawal 6 months, all transference cures of affected part, walking has recovered work capacity freely fully, and existing a year and a half does not recur so far.
(6) Luan Fuyi; The man, 61 years old, cervical region hypertrophy, clinical symptoms had that migraine, left arm fiber crops are expanded, shoulder is ached, restriction of neck motion, shoulder lower part, left side skin become undesired redness.Take this medicine after two courses of treatment, symptom complete obiteration, not recurrence in 2 years so far.
(7) Sun Hongwei: woman, 44 years old, thoracic vertebra four joint hypertrophy.This patient's medical history is short, symptom is but very heavy, and clinical symptoms has, the above limited in rotation of waist, both arms dare not on lift, the sitting lying on bed for a long time more can increase symptom.Work capacity is lost substantially, need lean on other people to help when putting on clothing.Symptom disappears substantially after two courses of treatment, can go up a hill and participate in some work.In drug withdrawal symptom complete obiteration after month, do not see recurrence again in three months, and cured sky surplus in the of totally 50 in 3 years so far from treating to.
Process for preparation below in conjunction with this medicated wine provides embodiments of the invention.
Embodiment 1.100 kilograms of preparation raw material of Chinese medicine weigh drying, 18 kilograms on pure Flos Carthami (18%), 25 kilograms of Radix Angelicae Sinensis (25%), 28 kilograms of the Cortexs Eucommiae (28%), 18 kilograms of Radix Achyranthis Bidentataes (18%), 11 kilograms of Radix Scrophulariaes (11%).Mix the back pulverization.Weigh 150-200 kilogram Chinese liquor then, again 100 kilograms of raw material of Chinese medicine and 150-200 kilogram Chinese liquor are put into a container, the closed container mouth is deposited and can be sold in 5-30 days.Also can by every bag 300-400 gram packing, allow the patient get it filled the back, the back Chinese liquor infusion of going home raw material of Chinese medicine according to its explanation.After 5-30 days, with the amount drink medicated wine of each 30-45 gram.Owing to do not have Moschus in the present embodiment, so drug effect is more inferior slightly.
Embodiment 2.100 kilograms of same preparation raw material of Chinese medicine weigh drying, 25 kilograms of pure Radix Salviae Miltiorrhizaes (25%), 20 kilograms of Radix Angelicae Sinensis (20%), 23 kilograms of the Cortexs Eucommiae (23%), 13,5 kilograms of Radix Achyranthis Bidentataes (13,5%), 18 kilograms of Radix Scrophulariaes (18%), 0,5 kilograms in Moschus (0,5%) mixes the back pulverization.The course of processing of back is identical with embodiment 1.With the distinctive points of embodiment 1 be, replaced Flos Carthami with Radix Salviae Miltiorrhizae, and increased Moschus, so drug effect is better, but cost has increased.
Embodiment 3.100 kilograms of the effective raw material of Chinese medicine of same preparation weigh drying, 30 kilograms of pure Herba Leonuris (30%), 22 kilograms of Radix Angelicae Sinensis (22%), 22 kilograms of the Cortexs Eucommiae (22%), 10 kilograms of Radix Achyranthis Bidentataes (10%), 15 kilograms of Radix Scrophulariaes (15%), 1 kilogram in Moschus (1%) mixes the back pulverization.The course of processing of back is identical with embodiment 1.With the distinctive points of embodiment 1 be, replaced Flos Carthami, and increased Moschus with Herba Leonuri, and more because of the Moschus amount, so drug effect is not bad than embodiment 2, but cost has increased.
Embodiment 4.100 kilograms of same preparation raw material of Chinese medicine weigh drying, 28 kilograms on pure Flos Carthami (28%), 23 kilograms of Radix Angelicae Sinensis (23%), 25 kilograms of the Cortexs Eucommiae (25%), 12,5 kilograms of Radix Achyranthis Bidentataes (12,5%), 10 kilograms of Radix Scrophulariaes (10%), 1,5 kilograms in Moschus (1,5%) mixes the back pulverization.The course of processing of back is identical with embodiment 1.With the distinctive points of embodiment 1 be, increased Moschus, so drug effect is better, but cost has increased.
The technical solution that in like manner provides according to the present invention can also provide other embodiment.What need further specify is that the Radix Angelicae Sinensis in the technology of the present invention solution can use one of Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Radix Polygoni Multiflori, Colla Corii Asini to replace.Radix Scrophulariae can use one of Radix Rehmanniae, Radix Paeoniae Rubra to replace.Affiliated Radix Achyranthis Bidentatae can be a Radix Cyathulae, also can be Radix Achyranthis Bidentatae.
Claims (3)
1, a kind of medicated wine for the treatment of hyperosteogeny is characterized in that: it is to put into Chinese liquor by the raw material of Chinese medicine of following weight percentage ratio to make Flos Carthami or Radix Salviae Miltiorrhizae or Herba Leonuri 18-30% basically, Radix Angelicae Sinensis 20-30%, Cortex Eucommiae 20-30%, Radix Achyranthis Bidentatae 10-20%, Radix Scrophulariae 10-18%.
2, according to the medicated wine of the described treatment hyperosteogeny of claim 1, it is characterized in that; The percentage by weight of raw material of Chinese medicine is Flos Carthami or Radix Salviae Miltiorrhizae or Herba Leonuri 18-25%, Radix Angelicae Sinensis 22-28%, Cortex Eucommiae 20-28%, Radix Achyranthis Bidentatae 12-18%, Radix Scrophulariae 12-15%.
3, according to the medicated wine of claim 1 or 2 described treatment hyperosteogenys, it is characterized in that: also have in the described raw material of Chinese medicine that Moschus, the percentage by weight of Moschus are 0,5-1,5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01107879A CN1127969C (en) | 2001-03-13 | 2001-03-13 | Hyperosteogeny treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01107879A CN1127969C (en) | 2001-03-13 | 2001-03-13 | Hyperosteogeny treating medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1331983A CN1331983A (en) | 2002-01-23 |
| CN1127969C true CN1127969C (en) | 2003-11-19 |
Family
ID=4656782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN01107879A Expired - Fee Related CN1127969C (en) | 2001-03-13 | 2001-03-13 | Hyperosteogeny treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1127969C (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101461866B (en) * | 2008-05-09 | 2012-06-20 | 张吉昌 | Method for preparing health-care medicinal liquor |
| CN103655911A (en) * | 2013-12-31 | 2014-03-26 | 纪元元 | Traditional Chinese medicine for treating hyperostosis and method for preparing traditional Chinese medicine |
| CN104383524B (en) * | 2014-11-27 | 2016-09-21 | 桂林瑞丰环保微生物应用研究所 | A kind of health product strengthening sclerotin |
| CN106215079A (en) * | 2016-07-18 | 2016-12-14 | 王恩禄 | A kind of Chinese medicine composition treating hyperosteogeny |
| CN107050138A (en) * | 2017-05-23 | 2017-08-18 | 四川何天祺医院管理有限公司 | Pharmaceutical composition and its preparation and paste preparation method for treating osteoproliferation |
| CN107496483A (en) * | 2017-09-07 | 2017-12-22 | 陈德先 | A kind of medicinal liquor for treating osteoproliferation |
| CN108969594A (en) * | 2018-10-23 | 2018-12-11 | 王崇彬 | A kind of Chinese materia medica preparation that treating osteoproliferation and preparation method |
| CN110051718A (en) * | 2019-05-31 | 2019-07-26 | 崔桂菊 | A kind of bone hyperplasia rehabilitation medicinal liquor |
-
2001
- 2001-03-13 CN CN01107879A patent/CN1127969C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1331983A (en) | 2002-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1127969C (en) | Hyperosteogeny treating medicine | |
| CN107050118A (en) | It is a kind of to treat Chinese medicine patch of caused by wind, cold and wetness evils and preparation method thereof | |
| CN100528194C (en) | Medicine for treating femoral head necrosis | |
| CN1814245A (en) | Chinese medicine remedy for treating cervical vertebra disease | |
| CN1435192A (en) | Jianzhoukang medicine for medicinal pillow for treating periomethritis and preparing method thereof | |
| CN1083377A (en) | Yaojingkang (drug for curing lumbar and cervical diseases) | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
| CN1259065C (en) | Chinese medicinal preparation for quick bone fracture setting | |
| CN104800663A (en) | Traditional Chinese medicinal liquor for treating hyperostosis and preparation method of traditional Chinese medicinal liquor | |
| CN104547222A (en) | Traditional Chinese medicine patching agent for treating hyperostosis | |
| CN104825563A (en) | Traditional Chinese medicine preparation for treating cervical spondylosis and preparation method thereof | |
| CN104547591A (en) | Pharmaceutical composition for treating acute ankle sprain | |
| CN100339095C (en) | Cervical spondylosis treating Chinese medicine composition | |
| CN1186084C (en) | Massage ointment for treating neck, shoulder, waist and leg pain, and extremity numbness | |
| CN1150921C (en) | Medicine for treating algia disease and its preparing process | |
| CN1284579C (en) | Oral medicine for treating ischemic necrosis of femoral head and its preparation | |
| CN1965927A (en) | Externally applied ointment for treating hyperosteogeny | |
| CN101049364A (en) | Umbilicus pasted powder for eliminating hernia | |
| CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN1234391C (en) | Spine osteopathy liquid | |
| CN1315520C (en) | Externally applied medicine for treating ischemic necrosis of femoral head and its preparation | |
| CN1230192C (en) | Medicine for treating protrasion of the lumbar intervertebral and preparation method | |
| CN103816481A (en) | Chinese medicine bag for treating cervical spondylosis, preparation method and application method thereof | |
| CN1069059C (en) | Chinese patent medicine for treating epilepsy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20031119 |